Diagnostic value of a superparamagnetic iron oxide in MR imaging of chronic liver disease in an animal model

American Journal of Roentgenology

Volumn 170, Issue 3, 1998, Pages 661-668

  Kreft, Burkhard ^a   Block, Wolfgang ^a   Dombrowski, Frank ^a   Fackeldey, Arndt ^a   Bachmann, Rainald ^a   Mühlhäuser, Jost ^a   Träber, Frank ^a   Øksendal, Audun ^b   Pfeifer, Ulrich ^a   Schild, Hans H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NYCOMED IMAGING AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; NSR 0430; SUPERPARAMAGNETIC IRON OXIDE; THIOACETAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC LIVER DISEASE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; LIVER CIRRHOSIS; LIVER FIBROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

EID: 0031908345     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.170.3.9490949     Document Type: Article

References (34)

1. Stark DD, Goldberg HI, Moss AA, et al. Chronic liver disease: evaluation by magnetic resonance. Radiology 1984;150:149-151
2. Kreft BP, Tanimoto A, Baba Y, et al. Diagnosis of fatty liver with MR imaging. J Magn Reson Imaging 1992;2:463-471
3. Elizondo G, Weissleder R, Stark DD, et al. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 1990;174:797-801
4. The Clinical NMR Group. Magnetic resonance imaging of parenchymal liver disease: a comparison with ultrasound, radionuclide scintigraphy and X-ray computed tomography. Clin Radiol 1987;38:495-502
5. Chameleau RA, Creyghton JH, De Nie I, Moerland MA, Van der Lende OR, Smidt J. Is the magnetic resonance imaging proton spin-lattice relaxation time a reliable noninvasive parameter of developing liver fibrosis? Hepatology 1988;8:217-221
6. Mitchell DG. Focal manifestations of diffuse liver disease at MR Imaging. Radiology 1992;185:1-11
7. Elizondo G, Fretz CJ, Stark DD, et al. Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging, Radiology 1991;178:73-78
8. Fretz CJ, Stark DD, Metz CE, et al. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR 1990;155:763-770
9. Stark DD, Weissleder R, Elizondo G, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988;168:297-301
10. Marchal G, van Hecke P, Demaerel P, et al. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. AJR 1989;152:771-775
11. Saini S. Advances in contrast-enhanced MR imaging: principles. AJR 1991;156:236-238
12. Lim KO, Stark DD, Leese PT, Pfefferbaum A, Rocklage SM, Quay SC. Hepatobiliary MR imaging: first human experience with Mn-DPDP. Radiology 1991;178:79-82
13. Reimer P, Weissleder R, Lee AS, Büttner S, Wittenberg J, Brady TJ. Asialoglycoprotein receptor function in benign fiver disease: evaluation with MR imaging. Radiology 1991;78:769-774
14. Proctor E, Chatamra K. Controlled induction of cirrhosis in the rat. Br J Exp Pathol 1983;64:320-330
15. McLean EK, McLean AE, Sutton PM. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone. Br J Exp Pathol 1969;50:502-506
16. Eichler O, Farah A, Herken H, Welch AD. Experimental production of diseases. In: Born GV, ed. Handbuch der Experimentellen Pharmakologie. Berlin: Springer, 1976:31-41
17. Tamayo RP. Is cirrhosis of the liver experimentally produced by CC14 an adequate model of human cirrhosis? Hepatology 1983;3:112-120
18. Thoenes W, Bannasch P. Elektronen- und lichtmikroskopische Untersuchungen am Cytoplasma der Leberzellen nach akuter und chronischer Thioacetamid-Vergiftung. Virchows Arch Pathol Anat 1962;335:556-583
19. Hirner A. Häring R, Karavias T. Die experimentelle Thioacetamidzirrhose der Ratte im Vergleich sur humane Zirrhose. In: Zelder O, Röher HD, Fischer M, Bode I, eds. Experimentelle und klinische Hepatologie. Stuttgart: Hippokrates, 1981:127-130
20. Brodehl J. Thioacetamid in der experimentellen Leberforschung. Klin Wochenschr 1961;39:956-962
21. Stöcker E. Autoradiographische Studien zum Einfluß von Thioacetamid auf den zellulären Eiweißund Nukleinsäurestoffwechsel in Leberzellen der Ratte. Beitr Pathol Anat 1964;129:247
22. Aherne WA, Dunnill MS. Point counting and the estimation of volume fraction. In: Aherne WA, Dunnill MS, eds. Morphometry. London: Arnold, 1982:33-45
23. Greenwel P, Geerts A, Ogata I, et al. Liver fibrosis. In: Arias M, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shasritz DA, eds. The liver: biology and pathobiology, 3rd ed. New York: Raven, 1994:1367-1377
24. Itai Y, Ohtomo K. Hepatitis, fatty liver, and cirrhosis. In: Ferrucci JT, Stark DD, eds. Liver imaging: current trends and new techniques. Boston: Andover Medical, 1990:306-313
25. DiLelio A, Cestavi C, Lowazzi A, et al. Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology 1989;172:389-392
26. Ohtomo K, Itai Y, Ohtomo Y, et al. Regenerating nodules of liver cirrhosis: MR imaging with pathologic correlation. AJR 1990;154:505-507
27. Murakami T, Nakamura H, Shinichi H, et al. CT and MRI of siderotic regenerating nodules in hepatic cirrhosis. J Comput Assist Tomogr 1992;16:578-582
28. Hannesson PH, Wallengren NO, Lyttkens K, Melin T, Brockstedt S, Stahlberg F. Magnetic resonance imaging with signal-intensity measurements in diffuse liver disease. Eur Radiol 1995;5:626-629
29. Clement O, Chamborn C, Schouman-Clayes E, et al. Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging. Radiology 1991;180:31-36
30. Hamazaki K, Sato S, Yunoki M, et al. Kupffer cell function in chronic liver injury and after partial hepatectomy. Res Exp Med 1994;194:237-246
31. 4-induced liver cirrhosis. Res Exp Med 1990;190:173-182
32. 4-induced liver cirrhosis. Int J Exp Pathol 1993;74:229-236
33. Geerts A, Schellinck P, Bouwens L. Cell population kinetics of Kupffer cells during the onset of fibrosis in rat liver by chronic tetrachloride administration. J Hepatol 1988;6:50-56
34. Paumgartner G, Longueville J, Leevy CM. Phagocytic activity in experimental liver injury. Exp Mol Pathol 1968;9:161-170